Cargando…
Biology of portal hypertension
Portal hypertension develops as a result of increased intrahepatic vascular resistance often caused by chronic liver disease that leads to structural distortion by fibrosis, microvascular thrombosis, dysfunction of liver sinusoidal endothelial cells (LSECs), and hepatic stellate cell (HSC) activatio...
Autores principales: | McConnell, Matthew, Iwakiri, Yasuko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer India
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7090883/ https://www.ncbi.nlm.nih.gov/pubmed/29075990 http://dx.doi.org/10.1007/s12072-017-9826-x |
Ejemplares similares
-
Novel serological neo-epitope markers of extracellular matrix proteins for the detection of portal hypertension
por: Leeming, D J, et al.
Publicado: (2013) -
Pediatric portal hypertension: A review for primary care
por: Vogel, Clarissa Barbon
Publicado: (2017) -
Hepatic encephalopathy: a critical current review
por: Hadjihambi, Anna, et al.
Publicado: (2017) -
Impact of patatin‐like phospholipase domain containing 3 rs738409 G/G genotype on hepatic decompensation and mortality in patients with portal hypertension
por: Mandorfer, M., et al.
Publicado: (2018) -
SARC‐F combined with a simple tool for assessment of muscle abnormalities in outpatients with chronic liver disease
por: Hiraoka, Atsushi, et al.
Publicado: (2020)